Why is pancreatic cancer hard to detect early?

Early-stage pancreatic cancer is usually asymptomatic, and conventional CT misses about 40% of lesions under 2 cm — an objective limit of the human eye.

How does PANCREASaver work?

A CNN + radiomics dual-engine analyzes abdominal CT images (after contrast injection), flags suspicious lesions in real time, and triggers PACS alerts.

Do I need an extra pancreatic AI scan on my CT?

No. It analyzes existing abdominal CT images; please consult your physician about whether screening is appropriate.

Does an AI flag mean I have cancer?

An AI flag is a high-risk reminder for the physician to take a closer look; the final diagnosis is made by the physician.

Why does early detection matter?

When detected and treated under 2 cm, the five-year survival rate reaches about 80% (vs. under 10% at late stage).

Who should be screened?

High-risk groups (family history, new-onset diabetes, age 60+, long-term smoking) should discuss screening with their physician.

Where is the product available?

Deployed at multiple medical institutions and health check centers across Taiwan.

AI-Powered Early Detection

Catch it early.
Live it fully.

Pancreatic cancer shows almost no early symptoms. PANCREASaver® imaging AI finds it while the tumor is still under 2cm — buying you and your family the most precious treatment window.

Start the Journey For Clinicians Learn about the Health Taiwan Deep Cultivation Plan

92.1%Sensitivity (<2cm)

0.95Multi-center AUC

2000+Cases Interpreted (incl. clinical validation)

FDAFDA Breakthrough

Scroll to explore

Patient First

An ordinary-looking day, until AI spotted a hidden risk and changed everything

One morning, one checkup, one small circle — and a family that kept its tomorrow. Early detection changes everything.

06:00 AM · Dawn

A beautiful day to be out

It was his favorite kind of morning. Sunlight over the riverbank. He felt fine — he didn't know anything yet.

10:30 AM · Checkup

AI circled a small mark

In a routine abdominal CT, AI circled a 1.2cm tumor — so small the human eye almost missed it.

07:00 PM · Dinner

The whole family at the table

Because it was found early, options remained. The family sat together, laughing as always.

See the full day

The Care Journey

From screening to survivorship, every step guarded

Scroll through five stations — the complete path PANCREASaver® walks with patients and physicians.

Screening: why check regularly

Early pancreatic cancer is nearly silent. By the time symptoms appear, it is often no longer early. For high-risk groups, regular imaging screening is the only way to buy time.

Regular Checkups ｜ High-Risk Groups ｜ Health Centers

Detection: AI sees it at 1.2cm

After an abdominal CT, AI circles a 1.2cm tumor — 92.1% sensitivity under 2cm. What can be seen can be treated.

Interactive CT ｜ 92.1% Sensitivity

Diagnosis: the physician's double check

AI findings go to radiologists for review, then specialists confirm the diagnosis. AI doesn't replace physicians — it lets them see earlier and more precisely.

Radiologists ｜ Reading ｜ Double Confirmation

Treatment: early means options

A 1cm tumor and a metastasized one have completely different paths. Early detection means more surgical options and better odds.

Surgical Options ｜ Survival ｜ Multidisciplinary Team

Survivorship: live well, with family

After treatment comes regular follow-up. We protect more than a scan — we protect a home. Every ordinary day deserves protection.

Follow-up ｜ Quality of Life ｜ Live Fully

All-in-one evidence

From product to certification, all in one place.

Six themes covering the full picture of PANCREASaver® — swipe to explore.

Product

The world's first pancreatic cancer CT AI detection

A fully automated end-to-end system: analyzes CT scans as they finish, flags suspicious lesions within 5 minutes, integrated with hospital PACS/RIS.

Learn more

Clinical Data

Nationwide real-world validation of 1,473 cases, AUC 0.95

89.7% sensitivity, 92.8% specificity; 92.1% sensitivity for tumors <2cm — published in Radiology and The Lancet Digital Health.

View clinical data

Publications

5 international papers, every line verifiable.

Real papers in Lancet Digital Health, Radiology, BMC Cancer and more — bilingual topics, real abstracts and PubMed links.

Visit the publication hall

IP Portfolio

10 patents in Taiwan & US, building a technology moat.

System-level and method-level claims covering medical imaging analysis and ML-based pancreatic cancer detection — US medical AI patents are exceptionally hard to obtain.

View IP portfolio